Stocks/ENGN

Create a free account to see ACCE Scores

Sign up for free to unlock scores, score breakdowns, and stock analysis.

ENGN

↓ PDF (Pro)
enGene Therapeutics Inc. Common Stock
HealthcareBiotechnologyCanadaNASDAQ
$8.80
+11.53%today
MKT CAP
$590M
+15.0% · 1Y
Earnings History
-6.2%
-12.1%
-26.2%
+23.3%
Q2 '25
Q3 '25
Q4 '25
Q1 '26
Analyst Targets
Current price
$8.80
Low
$9.00
Analyst Mean
$23.27
High
$30.00
11 analystsStrong Buy
Full Financials
Trailing P/E-
Forward P/E-0.9x
EV/EBITDA-
Price/Sales-
Dividend Yield-
Revenue Growth YoY-
Earnings Growth YoY-
Revenue Growth QoQ-
5y Revenue CAGR-
5y Earnings CAGR-
Gross Margin-
Operating Margin-
Net Margin-
ROE-
Debt / Equity-
Free Cash Flow-
Insider Ownership0.1%
Institutional Ownership98.1%
Short % of Float2.55%
Days to Cover5.4d
1 Week+13.9%
1 Month-
3 Months-
6 Months-
YTD-
1 Year-
3 Years-
5 Years-
vs 50-day SMA-
vs 200-day SMA-
vs 52w High-
vs 52w Low-
Insider Transactions
FilerRoleTypeSharesPriceValueDate
FORBION GROWTH OPPORTUNITIES FUND I COOPERATIEF UABeneficial Owner of more than 10% of a Class of SecurityBuy561,797$8.90$5.00M2024-10-30
FORBION GROWTH OPPORTUNITIES FUND I COOPERATIEF UABeneficial Owner of more than 10% of a Class of SecurityBuy470,633$5.94$3.01M2024-10-08
COOPER RONALD HAROLD WILFREDChief Executive OfficerBuy10,000$5.70$0.06M2024-09-27
GLICKMAN RICHARD MDirectorConversion120$0.89$0.00M2024-05-28
Top Holders
HolderType% HeldValueΔ SharesAs of
FCPM III Services B.V.institution14.38%$0.08B+0.00%2025-12-31
Perceptive Advisors Llcinstitution8.76%$0.05B+179.85%2025-12-31
VR Adviser, LLCinstitution7.12%$0.04B-5.45%2025-12-31
Deep Track Capital, Lpinstitution6.53%$0.04B+95.48%2025-12-31
Cormorant Asset Management, LPinstitution5.97%$0.04B+72.15%2025-12-31
Blue Owl Capital Holdings LPinstitution5.02%$0.03B+2.53%2025-12-31
Siren, L.L.C.institution4.98%$0.03B+100.00%2025-12-31
Braidwell LP institution4.67%$0.03B+38.17%2025-12-31
Nextech Invest, Ltd.institution3.17%$0.02B+100.00%2025-12-31
Janus Henderson Group PLCinstitution2.84%$0.02B+100.00%2025-12-31
MUTUAL FUND SERIES TRUST-Eventide Healthcare & Life Sciences Fundfund1.42%$0.01B+100.00%2025-12-31
Franklin Strategic Series-FRANKLIN BIOTECHNOLOGY DISCOVERY FUNDfund0.73%$0.00B+35.36%2026-01-31
Fidelity Select Portfolios-Select Biotechnology Portfoliofund0.35%$0.00B+74.85%2026-02-28
Fidelity Concord Street Trust-Fidelity Nasdaq Composite Index Fundfund0.06%$0.00B+33.72%2026-02-28
ETFis Series Trust I-Virtus LifeSci Biotech Clinical Trials ETFfund0.05%$0.00B+100.00%2026-01-31
American Century ETF Trust-Avantis U.S. Small Cap Equity ETFfund0.05%$0.00B+0.00%2026-03-31
Exchange Place Advisors Trust-North Square Kennedy MicroCap Fundfund0.02%$0.00B+440.18%2026-02-28
TIFF INVESTMENT PROGRAM-TIFF Multi-Asset Fundfund0.01%$0.00B+100.00%2025-12-31
Northern Funds-SMALL CAP CORE FUNDfund0.01%$0.00B-6.96%2025-12-31
American Century ETF Trust-Avantis U.S. Equity Fundfund0.00%$0.00B-73.69%2026-03-31
TickerCapScoreP/EFwd P/EEV/EBITDAROEGrossD/EDiv
PTGX
Protagonist Therapeutics Inc. Common Stock
$6.6B5------0.00%
CELC
Celcuity Inc. Common Stock
$6.7B5------0.00%
ACLX
Arcellx Inc. Common Stock
$6.7B5-------
KYMR
Kymera Therapeutics Inc. Common Stock
$7.0B-----27.1%0%5.230.00%
TECH
Bio-Techne Corp Common Stock
$7.1B3672.724.4----63.00%
HALO
Halozyme Therapeutics Inc. Common Stock
$7.9B7325.56.6----0.00%
Peers selected by sector + industry + nearest market cap. Best in column highlighted green, worst red.
Unlock Full Financials
Growth metrics, valuation multiples, and profitability ratios on Starter+.
Upgrade from $15/mo →
Growth73Value58Quality82Momentum61Total5
Score breakdown on Starter+
Upgrade →
Score History (90d)
Pro onlyUpgrade →
Updated 5/8/2026
Recent Alerts
No alerts yet for ENGN.
Want deep analysis?
This stock isn't in the ACCE researched universe. Browse 300+ stocks with full thesis, scores, and financial models.
Browse ACCE Indices →
Get the ACCE weekly digest
Index returns, picks recap, score movers - every Sunday. No fluff.